… and EMA, and many more are in clinical phase I-III trials. The FDA has issued recommendations to generate nonclinical biodistribut…
FDA
This funder is selected. Its supporting articles are shown below.
Articles mentioning FDA
90 articles · page 7 of 8…Background In May 2024, the FDA approved tarlatamab, a Delta-like ligand (DLL3)/CD3-targeted bi…
…t tool for MAb specificity that have been recommended in recent FDA guidance.Methods We developed a cell-based protein array, the M…
…tant setting, where treatment options remain limited. While the FDA has approved mirvetuximab soravtansine for platinum-resistant o…
…treatment options for this patient population. Lemborexant, the Food and Drug Administration (FDA)-approved dual orexin receptor antagonist for the treatmen…
…In the past three decades, the US Food and Drug Administration (FDA) has increasingly relied on surrogate endpoints (eg, disease-fr…
…cell depleting agent. Its effectiveness was obvious and in 2006 NICE approved it for use in rheumatoid arthritis.Working with other …
…tiation.29 When estimating the risk of cancer outcomes in older Medicare patients, censoring those who died before hypothetically experi…
…S, an oral cannabidiol solution, Epidiolex®, is approved by the FDA for the treatment of intractable seizures. We conducted an off-…
…the approval of a weekly subcutaneous injectable version by the Food and Drug Administration (FDA).…
…tegrating AI-enabled technologies within a clinical setting.The FDA has not approved any medical advice or algorithms based on AI i…